PASSERI DANIEL R

Average Profitability
0.83%
Insider Buys Quantity
8
Insider Buys Sum
$362,099.44
Insider Sells Quantity
31
Insider Sells Sum
$4.19M

Insider Activity of PASSERI DANIEL R

The largest purchase of all time was on 2018-08-16 and amounted to 12000 shares of Cue Biopharma, Inc. for $97,020.

The largest sale of all time was on 2004-12-06 and amounted to 116250 shares of Curis, Inc. for $582,215.

Biography of PASSERI DANIEL R

No biography is available at this moment.

2023-08-14PurchaseCue Biopharma, Inc.
CUE
CHIEF EXECUTIVE OFFICER
3,000
0.0065%
$2.86$8,580-31.51%
2021-09-24PurchaseCue Biopharma, Inc.
CUE
CHIEF EXECUTIVE OFFICER
3,400
0.011%
$14.72$50,051-65.45%
2019-06-21PurchaseCue Biopharma, Inc.
CUE
CEO and President
2,754
0.0128%
$7.26$19,994+67.87%
2019-06-06PurchaseCue Biopharma, Inc.
CUE
CEO and President
6,000
0.0277%
$6.90$41,400+62.33%
2018-08-16PurchaseCue Biopharma, Inc.
CUE
CEO and President
12,000
0.0592%
$8.09$97,020-8.23%
2018-06-29PurchaseCue Biopharma, Inc.
CUE
CEO and President
3,200
0.016%
$11.97$38,304-33.73%
2015-12-30SaleCuris, Inc.
CRIS
director
14,400
0.012%
$3.01$43,344-38.91%
2015-12-29SaleCuris, Inc.
CRIS
director
11,200
0.0088%
$2.91$32,592-40.13%
2015-12-28SaleCuris, Inc.
CRIS
director
11,000
0.0089%
$2.84$31,240-37.19%
2015-12-24SaleCuris, Inc.
CRIS
director
2,600
0.0021%
$2.90$7,540-38.28%
2015-12-23SaleCuris, Inc.
CRIS
director
10,900
0.0087%
$2.90$31,610-39.12%
2015-12-22SaleCuris, Inc.
CRIS
director
38,000
0.0301%
$2.75$104,500-36.3%
2015-12-21SaleCuris, Inc.
CRIS
director
100,000
0.0811%
$2.87$287,000-37.63%
2015-12-18SaleCuris, Inc.
CRIS
director
189,000
0.1563%
$3.05$576,450-40.13%
2013-05-08SaleCuris, Inc.
CRIS
CEO and Director
86,852
0.1034%
$3.70$321,352-13.19%
2013-05-07SaleCuris, Inc.
CRIS
CEO and Director
40,000
0.0497%
$3.63$145,200-7.36%
2013-05-06SaleCuris, Inc.
CRIS
CEO and Director
60,000
0.0746%
$3.66$219,600-7.85%
2013-05-03SaleCuris, Inc.
CRIS
CEO and Director
65,000
0.0799%
$3.73$242,450-10.43%
2013-05-02SaleCuris, Inc.
CRIS
CEO and Director
50,000
0.0611%
$3.66$183,000-9.08%
2012-12-06PurchaseCuris, Inc.
CRIS
CEO and Director
25,000
0.0317%
$3.03$75,750+15.73%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.